Author Correction: A selective inhibitor of mitofusin 1-βIIPKC association improves heart failure outcome in rats (2024)
- Authors:
- USP affiliated authors: FERREIRA, JULIO CESAR BATISTA - ICB ; DOURADO, PAULO MAGNO MARTINS - FM ; KOWALTOWSKI, ALÍCIA JULIANA - IQ ; CAMPOS, JULIANE CRUZ - ICB ; BOZI, LUIZ HENRIQUE MARCHESI - ICB ; BECHARA, LUIZ ROBERTO GRASSMANN - ICB ; LIMA, VANESSA MORAIS - ICB ; QUELICONI, BRUNO BARROS - IQ ; Dourado, Paulo Magno Martins - IQ
- Unidades: ICB; FM; IQ
- DOI: https://doi.org/10.1038/s41467-024-47288-3
- Subjects: ANATOMIA; INSUFICIÊNCIA CARDÍACA ANIMAL; RATOS; MODELOS ANIMAIS DE DOENÇAS; ORGANELAS CELULARES; MITOCÔNDRIAS
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título do periódico: Nature Communications
- ISSN: 2041-1723
- Volume/Número/Paginação/Ano: v. 15, art. 2889, 12 p., 2024
- Este periódico é de acesso aberto
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: gold
- Licença: cc-by
-
ABNT
FERREIRA, Julio Cesar Batista et al. Author Correction: A selective inhibitor of mitofusin 1-βIIPKC association improves heart failure outcome in rats. Nature Communications. London: Instituto de Ciências Biomédicas, Universidade de São Paulo. Disponível em: https://doi.org/10.1038/s41467-018-08276-6,. Acesso em: 29 maio 2024. , 2024 -
APA
Ferreira, J. C. B., Campos, J. C., Qvit, N., Qi, X., Bozi, L. H. M., Bechara, L. R. G., et al. (2024). Author Correction: A selective inhibitor of mitofusin 1-βIIPKC association improves heart failure outcome in rats. Nature Communications. London: Instituto de Ciências Biomédicas, Universidade de São Paulo. doi:https://doi.org/10.1038/s41467-024-47288-3 -
NLM
Ferreira JCB, Campos JC, Qvit N, Qi X, Bozi LHM, Bechara LRG, Lima VM, Queliconi BB, Disatnik M-H, Dourado PMM, Kowaltowski AJ, Rosen DM. Author Correction: A selective inhibitor of mitofusin 1-βIIPKC association improves heart failure outcome in rats [Internet]. Nature Communications. 2024 ; 15 12 .[citado 2024 maio 29 ] Available from: https://doi.org/10.1038/s41467-018-08276-6, -
Vancouver
Ferreira JCB, Campos JC, Qvit N, Qi X, Bozi LHM, Bechara LRG, Lima VM, Queliconi BB, Disatnik M-H, Dourado PMM, Kowaltowski AJ, Rosen DM. Author Correction: A selective inhibitor of mitofusin 1-βIIPKC association improves heart failure outcome in rats [Internet]. Nature Communications. 2024 ; 15 12 .[citado 2024 maio 29 ] Available from: https://doi.org/10.1038/s41467-018-08276-6, - Bicarbonato/C'OIND.2' aumenta dano em isquemia-reperfusão: da observação inicial à caracterização molecular
- Mitochondrial unfolded protein response (UPRmt) activation in cardiac diseases: opportunities and challenges
- Exercise preserves physical fitness during aging through AMPK and mitochondrial dynamics
- pH-Gated succinate secretion regulates muscle remodeling in response to exercise
- Mild mitochondrial impairment enhances innate immunity and longevity through ATFS-1 and p38 signaling
- A selective inhibitor of Cardiac Troponin I Phosphorylation by Delta Protein Kinase C (δPKC) as a treatment for Ischemia-reperfusion injury
- Comment on: “Aldehyde dehydrogenases contribute to skeletal muscle homeostasis in healthy, aging, and Duchenne muscular dystrophy patients” by Etienne et al.
- Mitophagy protects against statin-mediated skeletal muscle toxicity
- Mitochondrially-targeted treatment strategies
- β2‐adrenoceptor activation improves skeletal muscle autophagy in neurogenic myopathy
Informações sobre o DOI: https://doi.org/10.1038/s41467-024-47288-3 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
